These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27160883)

  • 1. Prescription Rates of Cardiovascular Medications in a Large UK Primary Care Chronic Kidney Disease Cohort.
    Major R; Shepherd D; Warwick G; Brunskill N
    Nephron; 2016; 133(1):15-22. PubMed ID: 27160883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with medical risk factors for chronic kidney disease are at increased risk of renal impairment despite the use of nephron-sparing surgery.
    Satasivam P; Reeves F; Rao K; Ivey Z; Basto M; Yip M; Roth H; Grummet J; Goad J; Moon D; Murphy D; Appu S; Lawrentschuk N; Bolton D; Kearsley J; Costello A; Frydenberg M
    BJU Int; 2015 Oct; 116(4):590-5. PubMed ID: 25676543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The unrecognized prevalence of chronic kidney disease in diabetes.
    Middleton RJ; Foley RN; Hegarty J; Cheung CM; McElduff P; Gibson JM; Kalra PA; O'Donoghue DJ; New JP
    Nephrol Dial Transplant; 2006 Jan; 21(1):88-92. PubMed ID: 16221715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.
    Karunaratne K; Stevens P; Irving J; Hobbs H; Kilbride H; Kingston R; Farmer C
    Nephrol Dial Transplant; 2013 Aug; 28(8):2107-16. PubMed ID: 23658247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: a cohort study.
    Bansal N; Hsu CY; Chandra M; Iribarren C; Fortmann SP; Hlatky MA; Go AS
    BMC Nephrol; 2011 Sep; 12():44. PubMed ID: 21917174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects.
    Bailie GR; Eisele G; Liu L; Roys E; Kiser M; Finkelstein F; Wolfe R; Port F; Burrows-Hudson S; Saran R
    Nephrol Dial Transplant; 2005 Jun; 20(6):1110-5. PubMed ID: 15769809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation.
    Skali H; Uno H; Levey AS; Inker LA; Pfeffer MA; Solomon SD
    Am Heart J; 2011 Sep; 162(3):548-54. PubMed ID: 21884875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and Recognition of Chronic Kidney Disease in VA Health Care System Primary Care Clinics.
    Bansal S; Mader M; Pugh JA
    Kidney360; 2020 Sep; 1(9):904-915. PubMed ID: 35369564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk profile, quality of life and care of patients with moderate and advanced CKD: The French CKD-REIN Cohort Study.
    Stengel B; Metzger M; Combe C; Jacquelinet C; Briançon S; Ayav C; Fouque D; Laville M; Frimat L; Pascal C; Herpe YE; Morel P; Deleuze JF; Schanstra JP; Lange C; Legrand K; Speyer E; Liabeuf S; Robinson BM; Massy ZA
    Nephrol Dial Transplant; 2019 Feb; 34(2):277-286. PubMed ID: 29635335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
    Tokmakova MP; Skali H; Kenchaiah S; Braunwald E; Rouleau JL; Packer M; Chertow GM; Moyé LA; Pfeffer MA; Solomon SD
    Circulation; 2004 Dec; 110(24):3667-73. PubMed ID: 15569840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of early kidney damage in hospitalized patients with chronic kidney disease: a multicenter study.
    Chen N; Pan XX; Gu Y; Mao PJ; Ni ZH; Ding XQ; Zhang JH; Wang NS; Yuan WJ; Zhang JY
    Ren Fail; 2012; 34(3):329-33. PubMed ID: 22250704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The validity of searching routinely collected general practice computer data to identify patients with chronic kidney disease (CKD): a manual review of 500 medical records.
    Anandarajah S; Tai T; de Lusignan S; Stevens P; O'Donoghue D; Walker M; Hilton S
    Nephrol Dial Transplant; 2005 Oct; 20(10):2089-96. PubMed ID: 16030033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney measures with diabetes and hypertension on cardiovascular disease: the Atherosclerosis Risk in Communities Study.
    Alexander N; Matsushita K; Sang Y; Ballew S; Mahmoodi BK; Astor BC; Coresh J
    Am J Nephrol; 2015; 41(4-5):409-17. PubMed ID: 26139323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice.
    New JP; Middleton RJ; Klebe B; Farmer CK; de Lusignan S; Stevens PE; O'Donoghue DJ
    Diabet Med; 2007 Apr; 24(4):364-9. PubMed ID: 17335468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease.
    Kalra PA; Chrysochou C; Green D; Cheung CM; Khavandi K; Sixt S; Rastan A; Zeller T
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):1-10. PubMed ID: 19937777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function, concomitant medication use and outcomes following acute coronary syndromes.
    Reddan DN; Szczech L; Bhapkar MV; Moliterno DJ; Califf RM; Ohman EM; Berger PB; Hochman JS; Van de Werf F; Harrington RA; Newby LK
    Nephrol Dial Transplant; 2005 Oct; 20(10):2105-12. PubMed ID: 16030030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.